# Where to inject peptides under the skin · PepVault guides

Source: https://pepvault.app/guides/where-to-inject-peptides

Last updated: 2026-10-22

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [Getting started](https://pepvault.app/guides#getting-started)

# Where to inject peptides under the skin

Reviewed October 2026 12 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Where to inject subcutaneous peptides: belly, thigh or upper arm, how far from the navel, why rotating sites matters, and what is normal at the site after.

- **Last reviewed:** Oct 22, 2026
- **Sources:** 12
- **Questions:** 9
- **Compounds:** 3

## The short answer

Inject subcutaneous peptides into the fat just under the skin: the belly at least 5 cm (2 inches) from the navel, the front or outer thigh, or the back of the upper arm. Use a new spot each time, at least 2.5 cm (an inch) from the last, and skip skin that is bruised, scarred, tender or lumpy.

[PepVault research](https://pepvault.app/guides/how-we-research) · Last reviewed October 22, 2026 · [12 sources](https://pepvault.app/guides/where-to-inject-peptides#sources)

**Evidence:** FDA labels for semaglutide and tirzepatide for the sites, absorption and site reactions; human insulin-injection studies and expert consensus for technique and rotation; one rat study for BPC-157. Site-specific data for peptides exist only for the approved GLP-1s.

## Why does a peptide go into fat, not muscle?

In adults with diabetes, about 14 mm of fat sits under the skin of the belly, on average. That layer is where a subcutaneous peptide is meant to land. Ultrasound of 388 US adults with diabetes measured an average of 13.9 mm of fat on the belly, 10.4 mm on the thigh, 10.8 mm on the back of the arm and 15.4 mm on the buttocks, under skin only about 2 mm thick. Women carried about 5 mm more fat than men[4](https://pepvault.app/guides/where-to-inject-peptides#source-4).

The labels for semaglutide and tirzepatide say to inject under the skin and not into a muscle or a vein[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [2](https://pepvault.app/guides/where-to-inject-peptides#source-2). Muscle absorbs differently: in people who inject insulin, a shot that reaches muscle by mistake can be absorbed faster than intended[3](https://pepvault.app/guides/where-to-inject-peptides#source-3). From the fat, semaglutide reaches its peak in the blood 1 to 3 days after the injection[2](https://pepvault.app/guides/where-to-inject-peptides#source-2).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where exactly on the body?

The labels for the approved GLP-1 peptides name three areas, and so do general patient guides for any under-the-skin injection[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [2](https://pepvault.app/guides/where-to-inject-peptides#source-2) [5](https://pepvault.app/guides/where-to-inject-peptides#source-5):

- **Belly:** below the ribs and above the hip bones, at least 5 cm (2 inches) from the navel[2](https://pepvault.app/guides/where-to-inject-peptides#source-2) [5](https://pepvault.app/guides/where-to-inject-peptides#source-5).
- **Thigh:** the front and outer side of the upper thigh[2](https://pepvault.app/guides/where-to-inject-peptides#source-2) [5](https://pepvault.app/guides/where-to-inject-peptides#source-5).
- **Back of the upper arm:** at least 7.6 cm (3 inches) below the shoulder and 7.6 cm above the elbow[5](https://pepvault.app/guides/where-to-inject-peptides#source-5). The tirzepatide label says another person should give the injection here[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).

People who inject insulin also use the upper outer buttock, and it carries the thickest fat of the four sites measured[4](https://pepvault.app/guides/where-to-inject-peptides#source-4). The GLP-1 labels don't list it, so your product's own instructions come first.

To see each site on a body, with the skin opened up to scale so you can see where the needle tip sits in the fat, open PepVault's free 3D Injection Guide at pepvault.app/lab/injection. It walks through the steps for a vial and syringe, a multi-dose pen or a single-dose pen.

## Does the injection site change how much you absorb?

For the two most studied peptides, no. The semaglutide and tirzepatide labels state that similar exposure was achieved whether the injection went into the belly, thigh or upper arm[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [2](https://pepvault.app/guides/where-to-inject-peptides#source-2) [6](https://pepvault.app/guides/where-to-inject-peptides#source-6) [7](https://pepvault.app/guides/where-to-inject-peptides#source-7). The semaglutide label adds that the injection site can be changed without any change to the dose[2](https://pepvault.app/guides/where-to-inject-peptides#source-2).

Where sites do differ is in how much liquid seeps back out. In human injection data, belly injections leaked less than thigh injections. In pig tissue, waiting at least 3 seconds before pulling the needle out leaked less than pulling it out straight away[8](https://pepvault.app/guides/where-to-inject-peptides#source-8).

We found no published site comparison for research peptides such as BPC-157, so the GLP-1 labels and the insulin research are the best guide available.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Getting started path

- [How to reconstitute tirzepatide](https://pepvault.app/guides/how-to-reconstitute-tirzepatide)
- [How to reconstitute semaglutide](https://pepvault.app/guides/how-to-reconstitute-semaglutide)
- [How many units is 2.5 mg of tirzepatide?](https://pepvault.app/guides/how-many-units-is-2-5-mg)
- [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Vial](https://pepvault.app/glossary/vial)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

## Why rotate injection sites?

Injecting the same patch again and again can build a rubbery, thickened area of fat called lipohypertrophy. In a study of 430 people who inject insulin, 64.4% had it. Among those who rotated sites correctly, only 5% did, and 98% of the people who had it either did not rotate or rotated incorrectly. Reusing needles more than five times raised the risk too[9](https://pepvault.app/guides/where-to-inject-peptides#source-9).

It matters because that tissue absorbs less evenly. When 13 people with type 1 diabetes injected insulin into lipohypertrophy instead of normal fat, absorption over the first four hours fell by about a fifth, and it became far less predictable from one injection to the next[10](https://pepvault.app/guides/where-to-inject-peptides#source-10). Expert injection guidance says not to inject into these areas, and that correct rotation helps prevent them[11](https://pepvault.app/guides/where-to-inject-peptides#source-11).

The tirzepatide label asks you to rotate within the area you choose, to lower the risk of pits, thickened skin or lumps at injection sites[1](https://pepvault.app/guides/where-to-inject-peptides#source-1). In practice:

- Use a new spot every time, at least 2.5 cm (1 inch) from the last[5](https://pepvault.app/guides/where-to-inject-peptides#source-5).
- You can stay in the same area, just not the same spot[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).
- One easy rhythm (a habit, not a label rule): split the belly into four quarters around the navel, keeping 5 cm clear of it, and move round them in one direction, one injection per quarter.
<!--promo-->
- PepVault logs the site with each dose (left or right belly, thigh, back of the arm and more) and pre-selects the site in your rotation that you used longest ago.
<!--/promo-->

## Pinch or no pinch, and at what angle?

This depends on the needle, and the evidence comes from insulin, where the depth of skin and fat has been measured by ultrasound. Expert guidance names the shortest needles, the 4 mm pen needle and the 6 mm syringe needle, as the first choice for all patients: safe, effective and less painful[11](https://pepvault.app/guides/where-to-inject-peptides#source-11). Inserted at 90°, a 4 or 5 mm needle stays in the fat in virtually all adults[4](https://pepvault.app/guides/where-to-inject-peptides#source-4).

Longer needles are where the pinch earns its place. With an 8 mm needle inserted straight in without a pinch, the estimated chance of reaching muscle was 25% in the thigh and 9.7% in the belly, against 1.6% and 0.1% with a 4 mm needle. Going in at 45° lowers that chance with longer needles[3](https://pepvault.app/guides/where-to-inject-peptides#source-3). The thigh carries the least fat of the four sites, and the estimated risk of reaching muscle was highest there[3](https://pepvault.app/guides/where-to-inject-peptides#source-3) [4](https://pepvault.app/guides/where-to-inject-peptides#source-4).

- **4 mm pen needle:** straight in at 90°, which keeps the tip in the fat for nearly every adult[4](https://pepvault.app/guides/where-to-inject-peptides#source-4).
- **Insulin syringe:** pinch about 2.5 cm (an inch) of skin and fat, not muscle, between your fingers and go in at 90°, or at 45° if there is not much fat[5](https://pepvault.app/guides/where-to-inject-peptides#source-5).
- **Single-dose pen:** no pinch step; the base goes flat against the skin[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).

Your product's instructions come first. The tirzepatide vial instructions, for example, say your healthcare provider should tell you whether to pinch the skin[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).

## Pen or syringe: what changes?

The sites are the same. What changes is how long the needle stays in. A single-dose tirzepatide pen is pressed and held for up to 10 seconds[1](https://pepvault.app/guides/where-to-inject-peptides#source-1). Semaglutide's multi-dose pen is held for a count of 6 seconds with the button pressed[7](https://pepvault.app/guides/where-to-inject-peptides#source-7). With a tirzepatide vial and syringe, the needle stays in the skin for at least 5 seconds[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).

A drop of liquid or blood on the skin afterwards is normal: press a cotton ball or gauze on the spot and don't rub it[1](https://pepvault.app/guides/where-to-inject-peptides#source-1). Every needle is single-use. The tirzepatide label says to use a new syringe and needle for each injection[1](https://pepvault.app/guides/where-to-inject-peptides#source-1), and needle reuse was one of the risk factors for lipohypertrophy above[9](https://pepvault.app/guides/where-to-inject-peptides#source-9).

## Which skin should you skip?

- Skin that is tender, bruised, red, scaly or hard[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [2](https://pepvault.app/guides/where-to-inject-peptides#source-2).
- Scars, stretch marks or damaged skin[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [2](https://pepvault.app/guides/where-to-inject-peptides#source-2).
- Pits, thickened skin or lumps from earlier injections[1](https://pepvault.app/guides/where-to-inject-peptides#source-1).
- The 5 cm (2 inches) around the navel[2](https://pepvault.app/guides/where-to-inject-peptides#source-2).

Start with clean, dry skin. Many instructions add an alcohol wipe; if you use one, let the skin dry before you inject[2](https://pepvault.app/guides/where-to-inject-peptides#source-2) [5](https://pepvault.app/guides/where-to-inject-peptides#source-5).

## Is redness, a bump or a bruise normal?

Yes. Some soreness at the spot is expected[5](https://pepvault.app/guides/where-to-inject-peptides#source-5). In the weight-loss trials, injection-site reactions such as redness, itching, bruising or pain were reported in 6 to 8% of people on tirzepatide, against 2% on placebo[1](https://pepvault.app/guides/where-to-inject-peptides#source-1). On semaglutide for weight loss, reactions such as itching, redness or a firm spot were reported in 1.4%, against 1% on placebo[2](https://pepvault.app/guides/where-to-inject-peptides#source-2).

Simple care covers most of it: press, don't rub[1](https://pepvault.app/guides/where-to-inject-peptides#source-1), and give that spot a rest by choosing a fresh one next time[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [5](https://pepvault.app/guides/where-to-inject-peptides#source-5). A firm or thickened patch that stays is one to skip, and rotating helps keep new ones from forming[1](https://pepvault.app/guides/where-to-inject-peptides#source-1) [9](https://pepvault.app/guides/where-to-inject-peptides#source-9).

Redness that spreads, swelling, red streaks or a fever can be signs of an infection and are a reason to contact your clinician[5](https://pepvault.app/guides/where-to-inject-peptides#source-5).

## What do people report?

**Commonly reported:** the belly is the easiest site to reach and the one most people settle on; the thigh stings a little more for some; a small pink or itchy patch that fades within a day or two is the most common complaint; and many BPC-157 users inject under the skin close to the sore tendon or joint.

These are user reports, not trial results. On the BPC-157 habit: a well-known rat study of a detached Achilles tendon gave the peptide by injection into the belly cavity, well away from the tendon, and still found better healing in strength, function and collagen[12](https://pepvault.app/guides/where-to-inject-peptides#source-12). We found no study that compares injecting near an injury with injecting elsewhere.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection: prescribing information, patient information and instructions for use. DailyMed, revised 08/2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. Novo Nordisk. WEGOVY (semaglutide) injection: prescribing information, patient information and instructions for use. DailyMed, revised 06/2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Hirsch L, Byron K, Gibney M. Intramuscular risk at insulin injection sites: measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes Technol Ther. 2014. [PubMed 25329935](https://pubmed.ncbi.nlm.nih.gov/25329935/)
4. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010. [PubMed 20429833](https://pubmed.ncbi.nlm.nih.gov/20429833/)
5. MedlinePlus (US National Library of Medicine). Subcutaneous (SQ) injections. Medical Encyclopedia. [medlineplus.gov](https://medlineplus.gov/ency/patientinstructions/000430.htm)
6. Eli Lilly and Company. MOUNJARO (tirzepatide) injection: prescribing information. DailyMed. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
7. Novo Nordisk. OZEMPIC (semaglutide) injection: prescribing information and instructions for use. DailyMed. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
8. Præstmark KA, Stallknecht B, Jensen ML et al. Injection technique and pen needle design affect leakage from skin after subcutaneous injections. J Diabetes Sci Technol. 2016. [PubMed 26798083](https://pubmed.ncbi.nlm.nih.gov/26798083/)
9. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013. [PubMed 23886784](https://pubmed.ncbi.nlm.nih.gov/23886784/)
10. Famulla S, Hövelmann U, Fischer A et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care. 2016. [PubMed 27411698](https://pubmed.ncbi.nlm.nih.gov/27411698/)
11. Frid AH, Kreugel G, Grassi G et al. New insulin delivery recommendations (FITTER). Mayo Clin Proc. 2016. [PubMed 27594187](https://pubmed.ncbi.nlm.nih.gov/27594187/)
12. Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006. [PubMed 16583442](https://pubmed.ncbi.nlm.nih.gov/16583442/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · Getting started

Guide · Getting started

### [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

What to pair with each peptide, and why: glycine and vitamin C for repair, less zinc on GHK-Cu, fasting and sleep for GH peptides, protein on GLP-1s.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [BPC-157 Studied range: 200–500 mcg](https://pepvault.app/peptides/bpc-157)

## Related guides

- Guide · Getting started

  ### [How to reconstitute tirzepatide](https://pepvault.app/guides/how-to-reconstitute-tirzepatide)

  How much bacteriostatic water to add to a tirzepatide vial, how to mix it, how to draw a dose in insulin-syringe units, and how to store it.

  Read the guide
- Guide · Stacks

  ### [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

  What to pair with each peptide, and why: glycine and vitamin C for repair, less zinc on GHK-Cu, fasting and sleep for GH peptides, protein on GLP-1s.

  Read the guide
- Guide · Recovery

  ### [BPC-157: the human data we have](https://pepvault.app/guides/bpc-157-human-data)

  Every published human study of BPC-157: the knee pain, bladder pain and IV safety pilots, what each found, the trials now registered, and how it works.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [All 20 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238)
- [All 15 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Getting started path

- [How to reconstitute tirzepatide](https://pepvault.app/guides/how-to-reconstitute-tirzepatide)
- [How to reconstitute semaglutide](https://pepvault.app/guides/how-to-reconstitute-semaglutide)
- [How many units is 2.5 mg of tirzepatide?](https://pepvault.app/guides/how-many-units-is-2-5-mg)
- [What to take alongside each peptide](https://pepvault.app/guides/what-to-take-with-peptides)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Vial](https://pepvault.app/glossary/vial)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
